Healthcare provider profile · identity verified

Keino Andre Rutherford, MD

Allopathic & Osteopathic Physicians|Internal Medicine · SHERMAN OAKS, CA · NPI 1497807853

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Keino Andre Rutherford, MD received $20.40 in general payments during 2025 across 1 reported records.

Otsuka America Pharmaceutical, Inc. accounted for 100.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 1 associated product.

A separate comparison found the same explicitly named product in public Medicare Part D data: Rexulti.

Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 160756 records involving 46288 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Rexulti by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$20.40

1 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Otsuka America Pharmaceutical, Inc.	Unresolved — no canonical attribution shown	$20.40	100.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$20.40	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
REXULTI Normalized: rexulti	Drug	Otsuka America Pharmaceutical, Inc.	$20.40	1	2025
Source payment records 2025-03-18 · Otsuka America Pharmaceutical, Inc. · $20.40 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
REXULTI rexulti	2025	Rexulti	2024	15 Beneficiary count suppressed	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference	2025	REXULTI open payments reported associated product	CMS Open Payments — General Payments 160756 supporting records · 46288 recipient NPIs · example record 1227267708	Rexulti · 2024 Exact normalized brand match · 1 Part D row	15	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1300	246
Divalproex Sodium	Divalproex Sodium	889	138
Levothyroxine Sodium	Levothyroxine Sodium	854	109
Olanzapine	Olanzapine	771	119
Amlodipine Besylate	Amlodipine Besylate	701	119
Metformin Hcl	Metformin Hcl	674	108
Gabapentin	Gabapentin	650	126
Pantoprazole Sodium	Pantoprazole Sodium	643	140
Risperidone	Risperidone	570	91
Eliquis	Apixaban	557	76
Famotidine	Famotidine	522	98
Tamsulosin Hcl	Tamsulosin Hcl	485	84
Quetiapine Fumarate	Quetiapine Fumarate	466	91
Metoprolol Tartrate	Metoprolol Tartrate	442	86
Furosemide	Furosemide	398	73
Levetiracetam	Levetiracetam	366	65
Donepezil Hcl	Donepezil Hcl	353	51
Lisinopril	Lisinopril	346	68
Benztropine Mesylate	Benztropine Mesylate	343	65
Memantine Hcl	Memantine Hcl	313	44
Carvedilol	Carvedilol	289	55
Mirtazapine	Mirtazapine	284	63
Lorazepam	Lorazepam	255	82
Trazodone Hcl	Trazodone Hcl	253	57
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	248	39
Lactulose	Lactulose	238	44
Omeprazole	Omeprazole	234	45
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	224	65
Losartan Potassium	Losartan Potassium	221	48
Potassium Chloride	Potassium Chloride	207	37
Albuterol Sulfate	Albuterol Sulfate	206	37
Escitalopram Oxalate	Escitalopram Oxalate	199	45
Finasteride	Finasteride	199	30
Sertraline Hcl	Sertraline Hcl	195	40
Hydralazine Hcl	Hydralazine Hcl	194	41
Latanoprost	Latanoprost	189	33
Clopidogrel	Clopidogrel Bisulfate	171	36
Entresto	Sacubitril/Valsartan	162	17
Sodium Chloride	0.9 % Sodium Chloride	161	33
Humulin R	Insulin Regular, Human	156	39
Tramadol Hcl	Tramadol Hcl	152	41
Novolin R	Insulin Regular, Human	148	34
Tradjenta	Linagliptin	146	21
Chlorhexidine Gluconate	Chlorhexidine Gluconate	144	14
Simvastatin	Simvastatin	140	18
Combivent Respimat	Ipratropium/Albuterol Sulfate	133	32
Clonazepam	Clonazepam	128	30
Nifedipine Er	Nifedipine	128	28
Xarelto	Rivaroxaban	127	13
Buspirone Hcl	Buspirone Hcl	122	23
Metoprolol Succinate	Metoprolol Succinate	122	28
Temazepam	Temazepam	122	37
Divalproex Sodium Er	Divalproex Sodium	118	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	118	30
Haloperidol	Haloperidol	116	18
Oxcarbazepine	Oxcarbazepine	114	18
Hydroxyzine Hcl	Hydroxyzine Hcl	109	33
Jardiance	Empagliflozin	109	21
Carbidopa-Levodopa	Carbidopa/Levodopa	108	15
Amiodarone Hcl	Amiodarone Hcl	107	18
Hydrochlorothiazide	Hydrochlorothiazide	105	23
Valproic Acid	Valproic Acid (As Sodium Salt)	103	22
Alendronate Sodium	Alendronate Sodium	100	18
Glucagon Emergency Kit	Glucagon	99	40
Albuterol Sulfate Hfa	Albuterol Sulfate	97	45
Spironolactone	Spironolactone	96	19
Clonidine Hcl	Clonidine Hcl	95	49
Fluoxetine Hcl	Fluoxetine Hcl	92	19
Glipizide	Glipizide	90	23
Duloxetine Hcl	Duloxetine Hcl	89	18
Januvia	Sitagliptin Phosphate	88	suppressed
Ibuprofen	Ibuprofen	86	52
Triamcinolone Acetonide	Triamcinolone Acetonide	83	45
Oxycodone Hcl	Oxycodone Hcl	82	14
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	81	29
Aripiprazole	Aripiprazole	80	19
Citalopram Hbr	Citalopram Hydrobromide	79	12
Ondansetron Hcl	Ondansetron Hcl	75	46
Sucralfate	Sucralfate	71	suppressed
Fluticasone Propionate	Fluticasone Propionate	70	22
Midodrine Hcl	Midodrine Hcl	69	16
Propranolol Hcl	Propranolol Hcl	69	12
Amantadine	Amantadine Hcl	66	suppressed
Meloxicam	Meloxicam	65	13
Lithium Carbonate	Lithium Carbonate	64	12
Rosuvastatin Calcium	Rosuvastatin Calcium	62	suppressed
Prednisone	Prednisone	59	39
Baclofen	Baclofen	58	14
Permethrin	Permethrin	58	51
Brimonidine Tartrate	Brimonidine Tartrate	57	11
Diclofenac Sodium	Diclofenac Sodium	57	15
Cephalexin	Cephalexin	56	52
Epogen	Epoetin Alfa	56	suppressed
Benazepril Hcl	Benazepril Hcl	55	11
Clozapine	Clozapine	55	suppressed
Digoxin	Digoxin	55	11
Mupirocin	Mupirocin	55	33
Oxybutynin Chloride	Oxybutynin Chloride	55	13
Santyl	Collagenase Clostridium Hist.	55	17
Clobetasol Propionate	Clobetasol Propionate	54	22
Pregabalin	Pregabalin	54	11
Warfarin Sodium	Warfarin Sodium	54	suppressed
Atenolol	Atenolol	53	suppressed
Timolol Maleate	Timolol Maleate	52	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	52	15
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	51	44
Creon	Lipase/Protease/Amylase	50	suppressed
Insulin Aspart Flexpen	Insulin Aspart	49	suppressed
Lamotrigine	Lamotrigine	49	suppressed
Novolog Flexpen	Insulin Aspart	49	suppressed
Glycopyrrolate	Glycopyrrolate	48	suppressed
Valsartan	Valsartan	48	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	47	suppressed
Dropsafe Pen Needle	Pen Needle, Diabetic, Safety	47	20
Methocarbamol	Methocarbamol	47	suppressed
Gemtesa	Vibegron	44	suppressed
Invega Sustenna	Paliperidone Palmitate	44	suppressed
Naloxone Hcl	Naloxone Hcl	43	20
Xifaxan	Rifaximin	43	suppressed
Bumetanide	Bumetanide	42	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	42	suppressed
Acetylcysteine	Acetylcysteine	41	suppressed
Allopurinol	Allopurinol	41	suppressed
Enalapril Maleate	Enalapril Maleate	41	suppressed
Nuplazid	Pimavanserin Tartrate	41	suppressed
Ketoconazole	Ketoconazole	40	15
Lidocaine	Lidocaine	40	19
Olanzapine Odt	Olanzapine	40	13
Topiramate	Topiramate	40	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	38	14
Ertapenem	Ertapenem Sodium	38	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	37	17
Fludrocortisone Acetate	Fludrocortisone Acetate	37	suppressed
Humalog	Insulin Lispro	37	12
Ranolazine Er	Ranolazine	37	suppressed
Valproic Acid	Valproic Acid	37	suppressed
Farxiga	Dapagliflozin Propanediol	36	suppressed
Levofloxacin	Levofloxacin	35	33
Novolog	Insulin Aspart	35	suppressed
Alprazolam	Alprazolam	34	suppressed
Azithromycin	Azithromycin	34	31
Oxybutynin Chloride Er	Oxybutynin Chloride	34	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	33	suppressed
Heparin Sodium	Heparin Sodium,porcine	33	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	33	suppressed
Haloperidol Decanoate	Haloperidol Decanoate	32	suppressed
Lacosamide	Lacosamide	32	suppressed
Megestrol Acetate	Megestrol Acetate	32	14
Budesonide	Budesonide	31	suppressed
Ingrezza	Valbenazine Tosylate	31	suppressed
Bupropion Xl	Bupropion Hcl	30	suppressed
Clotrimazole	Clotrimazole	30	16
Insulin Lispro Kwikpen U-100	Insulin Lispro	30	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	suppressed
Ezetimibe	Ezetimibe	29	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	28	suppressed
Armodafinil	Armodafinil	28	suppressed
Bupropion Hcl	Bupropion Hcl	28	suppressed
Cyclosporine	Cyclosporine	28	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	28	suppressed
Celecoxib	Celecoxib	27	suppressed
Ciclopirox	Ciclopirox Olamine	27	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Ipratropium Bromide	Ipratropium Bromide	27	12
Janumet Xr	Sitagliptin Phos/Metformin Hcl	27	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	27	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	27	suppressed
Pravastatin Sodium	Pravastatin Sodium	27	suppressed
Dutasteride	Dutasteride	26	suppressed
Carbamazepine	Carbamazepine	25	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	25	suppressed
Lamotrigine Er	Lamotrigine	25	suppressed
Nystatin	Nystatin	25	23
Premarin	Estrogens, Conjugated	25	suppressed
Rocklatan	Netarsudil Mesylat/Latanoprost	25	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Diazepam	Diazepam	23	suppressed
Icosapent Ethyl	Icosapent Ethyl	23	suppressed
Ivermectin	Ivermectin	23	14
Montelukast Sodium	Montelukast Sodium	23	suppressed
Nitroglycerin	Nitroglycerin	23	suppressed
Linzess	Linaclotide	22	suppressed
Otezla	Apremilast	22	suppressed
Ssd	Silver Sulfadiazine	22	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Brilinta	Ticagrelor	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Ceftriaxone	Ceftriaxone Sodium	20	13
Desmopressin Acetate	Desmopressin Acetate	20	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	20	suppressed
Hydrocortisone	Hydrocortisone	20	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Torsemide	Torsemide	20	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	20	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	19	suppressed
Lagevrio (Eua)	Molnupiravir	19	19
Ziprasidone Hcl	Ziprasidone Hcl	19	suppressed
Belbuca	Buprenorphine Hcl	18	suppressed
Labetalol Hcl	Labetalol Hcl	18	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	18	11
Meropenem	Meropenem	18	suppressed
Veltassa	Patiromer Calcium Sorbitex	18	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	17	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	17	suppressed
Nystop	Nystatin	17	suppressed
Ozempic	Semaglutide	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	17	suppressed
Fluphenazine Hcl	Fluphenazine Hcl	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	13
Novofine Autocover	Pen Needle, Diabetic, Safety	16	11
Novolin R Flexpen	Insulin Regular, Human	16	suppressed
Tigecycline	Tigecycline	16	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	11
Daptomycin	Daptomycin	15	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Levalbuterol Hcl	Levalbuterol Hcl	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	13
Ondansetron Odt	Ondansetron	15	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	15	suppressed
Piperacillin-Tazobactam	Piperacillin Sodium/Tazobactam	15	suppressed
Retacrit	Epoetin Alfa-Epbx	15	suppressed
Rexulti	Brexpiprazole	15	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	14	suppressed
Bromocriptine Mesylate	Bromocriptine Mesylate	14	suppressed
Cilostazol	Cilostazol	14	suppressed
Econazole Nitrate	Econazole Nitrate	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Lyvispah	Baclofen	14	suppressed
Memantine Hcl Er	Memantine Hcl	14	suppressed
Morphine Sulfate Er	Morphine Sulfate	14	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	14	11
Zoledronic Acid	Zoledronic Ac/Mannitol/0.9nacl	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Austedo Xr	Deutetrabenazine	13	suppressed
Bethanechol Chloride	Bethanechol Chloride	13	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	13	suppressed
Gemfibrozil	Gemfibrozil	13	suppressed
Methenamine Hippurate	Methenamine Hippurate	13	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	13	suppressed
Rivastigmine	Rivastigmine Tartrate	13	suppressed
Vancomycin Hcl	Vancomycin/Water For Inj (Peg)	13	suppressed
Atrovent Hfa	Ipratropium Bromide	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Clonidine	Clonidine	12	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	12	suppressed
Diltiazem Hcl	Diltiazem Hcl	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Hydroxyurea	Hydroxyurea	12	suppressed
Metformin Hcl Er	Metformin Hcl	12	suppressed
Potassium Citrate Er	Potassium Citrate	12	suppressed
Pulmicort	Budesonide	12	suppressed
Sevelamer Hcl	Sevelamer Hcl	12	suppressed
Calcitriol	Calcitriol	11	suppressed
Insulin Lispro	Insulin Lispro	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$20.40 · 1 records	Otsuka America Pharmaceutical, Inc.	REXULTI	1	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Rexulti play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with Otsuka America Pharmaceutical, Inc.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error